It's hard to be too concerned about this as they haven't provided data on dosing regimes or the results from the individual cell lines tested.
To your other point regarding IP sacrifice; > 6 months ago I would have agreed with you. RAC had effectively fallen flat on its face. We missed target dates and failed to deliver the new formulation. An ex-director departed and was presented with an opportunity to throw us under the bus. It was looking grim! A bad deal, early patent lodgement etc. might have turned it around, anything to validate the opportunity to the market and stave off third-party hostility. But, to management's credit, they didn't falter. They stayed the path and weathered the storm. That ex-director hasn't thrown us under the bus. We're now on the other side and it appears to be full steam ahead. To suggest this remains the course of action totally discredits what all shareholders have been through and where we are today.
We were lucky enough to get a peek behind the curtain with Doan et al, and we've got close ties to the leadership of the International Cardio Oncology Society. We can see the commercialisation strategy unfolding in front of us. The rerating SP is a protection against hostilities, so why not allow them the opportunity to remain silent (publicly) for a few short months until CPACS is ready to recruit?
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-405
-
-
- There are more pages in this discussion • 501 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.65 |
Change
0.050(3.13%) |
Mkt cap ! $281.1M |
Open | High | Low | Value | Volume |
$1.63 | $1.70 | $1.52 | $318.0K | 193.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 496 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.70 | 5484 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 496 | 1.650 |
1 | 22586 | 1.645 |
1 | 200 | 1.640 |
1 | 17732 | 1.630 |
1 | 25000 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.700 | 5484 | 2 |
1.720 | 581 | 1 |
1.745 | 12136 | 1 |
1.750 | 26309 | 3 |
1.755 | 990 | 1 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online